棘白菌素类与三唑类药物对多药耐药的相互作用。
Interactions of Echinocandins with Triazoles against Multidrug-Resistant .
机构信息
Department of Medical Parasitology and Mycology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran.
出版信息
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01056-17. Print 2017 Nov.
Abstract
We determined the interactions between echinocandins and azoles against 10 multidrug-resistant strains by use of a microdilution checkerboard technique. Our results suggest synergistic interactions between micafungin and voriconazole with fractional inhibitory concentration index (FICI) values of 0.15 to 0.5, and we observed indifferent interactions when micafungin was combined with fluconazole (FICI, 0.62 to 1.5). Combinations of caspofungin with fluconazole or voriconazole exhibited indifferent interactions. No antagonism was observed for any combination.
摘要
我们使用微量稀释棋盘技术确定了棘白菌素类药物和唑类药物对 10 株多药耐药菌株的相互作用。我们的结果表明，米卡芬净与伏立康唑之间存在协同作用，其部分抑菌浓度指数（FICI）值为 0.15 至 0.5，而米卡芬净与氟康唑联合使用时则表现为无关作用（FICI 值为 0.62 至 1.5）。卡泊芬净与氟康唑或伏立康唑联合使用时表现为无关作用。任何组合均未观察到拮抗作用。
相似文献
1
Interactions of Echinocandins with Triazoles against Multidrug-Resistant .棘白菌素类与三唑类药物对多药耐药的相互作用。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01056-17. Print 2017 Nov.
2
In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species.金奈达霉素与三唑类和棘白菌素类抗真菌药物体外抗常见和新兴念珠菌属种的相互作用。
Mycopathologia. 2019 Oct;184(5):607-613. doi: 10.1007/s11046-019-00370-7. Epub 2019 Aug 10.
3
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.棘白菌素类、两性霉素 B 和伏立康唑对氟康唑敏感和氟康唑耐药巴西光滑念珠菌分离株的活性。
Mem Inst Oswaldo Cruz. 2012 May;107(3):433-6. doi: 10.1590/s0074-02762012000300022.
4
Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.联合抗真菌药物对耐多药光滑念珠菌的活性。
Mycopathologia. 2017 Oct;182(9-10):819-828. doi: 10.1007/s11046-017-0141-9. Epub 2017 May 10.
5
Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak.针对来自纽约疫情的多重耐药耳念珠菌分离株的抗真菌药物联合评估
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02195-19.
6
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.米卡芬净与氟康唑、伏立康唑、两性霉素B和氟胞嘧啶对念珠菌属临床分离株的体外抗真菌联合作用。
J Infect Chemother. 2009 Feb;15(1):1-5. doi: 10.1007/s10156-008-0653-9. Epub 2009 Mar 12.
7
In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates.棘白菌素类与唑类药物体外抗氟康唑耐药近平滑念珠菌复合群的协同作用。
J Glob Antimicrob Resist. 2020 Jun;21:331-334. doi: 10.1016/j.jgar.2019.11.003. Epub 2019 Nov 9.
8
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.念珠菌属侵袭性分离株的体外药敏情况：氟康唑敏感剂量依赖性光滑念珠菌分离株的比例迅速上升。
Antimicrob Agents Chemother. 2008 Aug;52(8):2919-22. doi: 10.1128/AAC.00323-08. Epub 2008 May 5.
9
Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.一种长效棘白菌素（CD101）及七种对照抗真菌药物在2014年哨兵抗真菌监测项目中针对全球当代侵袭性真菌分离株集合的活性测试。
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02045-16. Print 2017 Mar.
10
Colistin interacts synergistically with echinocandins against Candida auris.黏菌素与棘白菌素类药物联合使用对耳念珠菌具有协同作用。
Int J Antimicrob Agents. 2020 Mar;55(3):105901. doi: 10.1016/j.ijantimicag.2020.105901. Epub 2020 Jan 17.
引用本文的文献
1
infection at a pediatric burn center: Treatment and infection control measures.儿科烧伤中心的感染：治疗与感染控制措施
North Clin Istanb. 2025 Jun 11;12(3):285-289. doi: 10.14744/nci.2024.26429. eCollection 2025.
2
Innovative antifungal strategies to combat drug-resistant : recent advances and clinical implications.对抗耐药性的创新抗真菌策略：最新进展与临床意义
Front Cell Infect Microbiol. 2025 Jul 31;15:1641373. doi: 10.3389/fcimb.2025.1641373. eCollection 2025.
3
Antifungal activity of polyphenolic compounds against fluconazole-susceptible and -resistant species.多酚类化合物对氟康唑敏感及耐药菌株的抗真菌活性。
Iran J Microbiol. 2025 Apr;17(2):342-347. doi: 10.18502/ijm.v17i2.18398.
4
The Gcn5 lysine acetyltransferase mediates cell wall remodeling, antifungal drug resistance, and virulence of .Gcn5赖氨酸乙酰转移酶介导细胞壁重塑、抗真菌药物抗性及（此处原文不完整，缺少具体对象）的毒力。
mSphere. 2025 Apr 29;10(4):e0006925. doi: 10.1128/msphere.00069-25. Epub 2025 Mar 11.
5
The multidrug-resistant complex and phylogenetic related species: Insights into antifungal resistance mechanisms.多重耐药复合体及系统发育相关物种：对抗真菌耐药机制的见解
Curr Res Microb Sci. 2025 Jan 28;8:100354. doi: 10.1016/j.crmicr.2025.100354. eCollection 2025.
6
: Epidemiology and Antifungal Strategy.流行病学与抗真菌策略
Annu Rev Med. 2025 Jan;76(1):57-67. doi: 10.1146/annurev-med-061523-021233. Epub 2025 Jan 16.
7
Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit .协同抑制的唑类组合药物和多靶点药物
J Fungi (Basel). 2024 Oct 7;10(10):698. doi: 10.3390/jof10100698.
8
Synergistic Effect of Essential Oils and Antifungal Agents in Fighting Resistant Clinical Isolates of .精油与抗真菌剂在对抗耐药临床分离株方面的协同作用。 （注：原文结尾处不完整）
Pharmaceutics. 2024 Jul 19;16(7):957. doi: 10.3390/pharmaceutics16070957.
9
The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England.实验室调查、管理以及感染预防和控制：一篇叙述性综述，旨在为 2024 年英格兰国家指南更新提供信息。
J Med Microbiol. 2024 May;73(5). doi: 10.1099/jmm.0.001820.
10
Outbreak in a Multidisciplinary Hospital in Romania during the Post-Pandemic Era: Potential Solutions and Challenges in Surveillance and Epidemiological Control.后疫情时代罗马尼亚一家多学科医院的疫情爆发：监测与流行病学控制中的潜在解决方案与挑战
Antibiotics (Basel). 2024 Apr 3;13(4):325. doi: 10.3390/antibiotics13040325.
本文引用的文献
1
The first cases of Candida auris candidaemia in Oman.阿曼首例耳念珠菌血症病例。
Mycoses. 2017 Sep;60(9):569-575. doi: 10.1111/myc.12647. Epub 2017 Jul 7.
2
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally.耳念珠菌：全球医院获得性多重耐药真菌感染的一个迅速出现的病因。
PLoS Pathog. 2017 May 18;13(5):e1006290. doi: 10.1371/journal.ppat.1006290. eCollection 2017 May.
3
Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris.新型葡聚糖合酶抑制剂SCY-078对耳念珠菌临床分离株的活性
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00435-17. Print 2017 Jul.
4
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.八种抗真菌化合物对耳念珠菌的欧盟CAST和CLSI参考微量稀释法最低抑菌浓度比较及相关暂定流行病学截断值
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00485-17. Print 2017 Jun.
5
Candida auris candidaemia in Indian ICUs: analysis of risk factors.印度重症监护病房中的耳念珠菌血症：危险因素分析
J Antimicrob Chemother. 2017 Jun 1;72(6):1794-1801. doi: 10.1093/jac/dkx034.
6
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.新兴病原体耳念珠菌：生长表型、毒力因子、抗真菌药物活性以及新型葡聚糖合成抑制剂SCY-078对生长形态和生物膜形成的影响
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02396-16. Print 2017 May.
7
Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins.在英国发现的新兴病原体耳念珠菌的分离株有多个地理来源。
Med Mycol. 2017 Jul 1;55(5):563-567. doi: 10.1093/mmy/myw147.
8
Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.多重耐药的哈氏假丝酵母菌和耳念珠菌，以色列特拉维夫
Emerg Infect Dis. 2017 Feb;23(1):195-203. doi: 10.3201/eid2302.161486.
9
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016.2013年5月至2016年8月美国对全球新出现的侵袭性、多重耐药真菌——耳念珠菌的前七例报告病例的调查。
Am J Transplant. 2017 Jan;17(1):296-299. doi: 10.1111/ajt.14121.
10
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.全基因组测序和流行病学分析证实三大洲同时出现多重耐药性耳念珠菌
Clin Infect Dis. 2017 Jan 15;64(2):134-140. doi: 10.1093/cid/ciw691. Epub 2016 Oct 20.
Zotero 插件